Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-01-19 00:00:00 ET · period of report 2023-01-17 · accession 0001209191-23-004005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-19 | 2023-01-17+ | VRTX | Lee Yuchun | Dir | M - OptEx | $72.14 | +4,442 | 2,317 | New | +$320.4K |
| DM | 2023-01-19 | 2023-01-17+ | VRTX | Lee Yuchun | Dir | S - Sale+OE | $312.04 | -4,442 | 1,875 | -70% | -$1.39M |
| DM | 2023-01-19 | 2023-01-17+ | VRTX | Lee Yuchun | Dir | M - OptEx | $0.00 | -4,442 | 15.6K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-17 | M | A | 4,000 | $72.14 | 5,875 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-18 | S | D | 442 | $312.17 | 1,875 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $312.17 (range $312.00 to $312.53). |
| 3 | Common | Common Stock | 2023-01-18 | M | A | 442 | $72.14 | 2,317 | D | — | — | |
| 4 | Common | Common Stock | 2023-01-17 | S | D | 4,000 | $312.03 | 1,875 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $312.03 (range $312.00 to $312.14). |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-01-17 | M | D | 4,000 | $0.00 | 16,000 | D | $72.14 · — to 2024-05-31 | 4,000 Common Stock | (F5) Fully vested. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-01-18 | M | D | 442 | $0.00 | 15,558 | D | $72.14 · — to 2024-05-31 | 442 Common Stock | (F5) Fully vested. |